FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948056601> ?p ?o ?g. }

• W2948056601 endingPage "OR" @default.
• W2948056601 startingPage "12" @default.
• W2948056601 abstract "High spending, especially out-of-pocket (OOP) payment on insulin, could lead individuals with diabetes to skip or ration doses and worsen future health outcomes. We examined the trends in total and OPP payment on a yearly supply of insulin by type from 2003 to 2016. Using the 2003-2016 MarketScan claims database, we analyzed 1,703,343 adults with diabetes who were continuously enrolled in fee-for-service health plans. Insulin was grouped into 6 types (human insulin, Glargine, Lispro, Aspart, Detemir and Glulisine) using National Drug Code. Total and OOP payment for each drug type were modelled at a 30-day supply level, and later multiplied by 12 to obtain yearly estimates. A joinpoint regression was used to identify inflection points and to estimate trends in each defined segment. Payments were standardized to 2016 USD. The total payment for insulin increased at annual rate of $162 per year from 2003 ($1982) to 2012 ($3686), followed by more than a 3-fold increase in the annual rate of increase to $708 per year between 2013 ($4392) and 2016 ($6250). By type, the annual rate of increases ranged from $64 (2%) for Glulisine to $133 (6%) for Glargine before the inflection point and raised to a range from $631 (16%) for Glargine to $1246 (26%) for Glulisine after the inflection point. OPP payment on a yearly supply of insulin decreased by $6 per year (-1.5%) between 2003 ($390) and 2009 ($384) followed by a 3% ($12) per year increase between 2010 ($405) and 2016 ($451). The annual rate of changes ranged from -$72 (14.8%) for Detemir to -$31 (-6%) for Glulisine before the inflection point and varied from $8 (2%) for Aspart to $41 (7.6%) for Glulisine after the inflection point. Total payment on a yearly supply of insulin had been increasing since 2003 but accelerated after 2011. The OPP payment reversed its trends from a decrease to an increase. But the much smaller increase in OPP payment than the total payment after 2011 suggests that payers bore most of the insulin spending increase. Disclosure H. Shao: None. M. Laxy: None. S.R. Benoit: None. Y.J. Cheng: None. E. Gregg: None. P. Zhang: None." @default.
• W2948056601 created "2019-06-14" @default.
• W2948056601 creator A5010850920 @default.
• W2948056601 creator A5014344323 @default.
• W2948056601 creator A5053317493 @default.
• W2948056601 creator A5055151897 @default.
• W2948056601 creator A5056137151 @default.
• W2948056601 creator A5079095481 @default.
• W2948056601 date "2019-06-01" @default.
• W2948056601 modified "2023-10-17" @default.
• W2948056601 title "12-OR: Trends in Total and Out-of-Pocket Payment on a Yearly Insulin Supply among Private Health Insured U.S. Adults with Diabetes from 2003 to 2016" @default.
• W2948056601 doi "https://doi.org/10.2337/db19-12-or" @default.
• W2948056601 hasPublicationYear "2019" @default.
• W2948056601 type Work @default.
• W2948056601 sameAs 2948056601 @default.
• W2948056601 citedByCount "0" @default.
• W2948056601 crossrefType "journal-article" @default.
• W2948056601 hasAuthorship W2948056601A5010850920 @default.
• W2948056601 hasAuthorship W2948056601A5014344323 @default.
• W2948056601 hasAuthorship W2948056601A5053317493 @default.
• W2948056601 hasAuthorship W2948056601A5055151897 @default.
• W2948056601 hasAuthorship W2948056601A5056137151 @default.
• W2948056601 hasAuthorship W2948056601A5079095481 @default.
• W2948056601 hasConcept C10138342 @default.
• W2948056601 hasConcept C134018914 @default.
• W2948056601 hasConcept C144133560 @default.
• W2948056601 hasConcept C145097563 @default.
• W2948056601 hasConcept C160735492 @default.
• W2948056601 hasConcept C162324750 @default.
• W2948056601 hasConcept C2983635472 @default.
• W2948056601 hasConcept C2992755240 @default.
• W2948056601 hasConcept C3020096462 @default.
• W2948056601 hasConcept C50522688 @default.
• W2948056601 hasConcept C555293320 @default.
• W2948056601 hasConcept C71924100 @default.
• W2948056601 hasConcept C99454951 @default.
• W2948056601 hasConceptScore W2948056601C10138342 @default.
• W2948056601 hasConceptScore W2948056601C134018914 @default.
• W2948056601 hasConceptScore W2948056601C144133560 @default.
• W2948056601 hasConceptScore W2948056601C145097563 @default.
• W2948056601 hasConceptScore W2948056601C160735492 @default.
• W2948056601 hasConceptScore W2948056601C162324750 @default.
• W2948056601 hasConceptScore W2948056601C2983635472 @default.
• W2948056601 hasConceptScore W2948056601C2992755240 @default.
• W2948056601 hasConceptScore W2948056601C3020096462 @default.
• W2948056601 hasConceptScore W2948056601C50522688 @default.
• W2948056601 hasConceptScore W2948056601C555293320 @default.
• W2948056601 hasConceptScore W2948056601C71924100 @default.
• W2948056601 hasConceptScore W2948056601C99454951 @default.
• W2948056601 hasIssue "Supplement 1" @default.
• W2948056601 hasLocation W29480566011 @default.
• W2948056601 hasOpenAccess W2948056601 @default.
• W2948056601 hasPrimaryLocation W29480566011 @default.
• W2948056601 hasRelatedWork W1976219352 @default.
• W2948056601 hasRelatedWork W2015603808 @default.
• W2948056601 hasRelatedWork W2339572343 @default.
• W2948056601 hasRelatedWork W2601788733 @default.
• W2948056601 hasRelatedWork W2775066161 @default.
• W2948056601 hasRelatedWork W2915130469 @default.
• W2948056601 hasRelatedWork W2970367902 @default.
• W2948056601 hasRelatedWork W315081357 @default.
• W2948056601 hasRelatedWork W4292405109 @default.
• W2948056601 hasRelatedWork W52954717 @default.
• W2948056601 hasVolume "68" @default.
• W2948056601 isParatext "false" @default.
• W2948056601 isRetracted "false" @default.
• W2948056601 magId "2948056601" @default.
• W2948056601 workType "article" @default.